These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 16207147)
21. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future. Alfirevic A; Pirmohamed M Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129 [TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice. Manolopoulos VG Clin Chem Lab Med; 2007; 45(7):801-14. PubMed ID: 17617019 [TBL] [Abstract][Full Text] [Related]
23. [Drug therapy and pharmacogenomics--hopes and facts]. Müller-Zellenberg U; Müller M Wien Med Wochenschr; 2005 Feb; 155(3-4):45-9. PubMed ID: 15791775 [TBL] [Abstract][Full Text] [Related]
24. Translating pharmacogenomics: challenges on the road to the clinic. Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640 [TBL] [Abstract][Full Text] [Related]
29. Defining the opportunity for pharmacogenetic intervention in primary care. Grice GR; Seaton TL; Woodland AM; McLeod HL Pharmacogenomics; 2006 Jan; 7(1):61-5. PubMed ID: 16354125 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics--10 years of progress: a cardiovascular perspective. Winkelmann BR; Herrington D Pharmacogenomics; 2010 May; 11(5):613-6. PubMed ID: 20415546 [TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Ingelman-Sundberg M Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083 [TBL] [Abstract][Full Text] [Related]
32. Drug delivery systems - an overview. Jain KK Methods Mol Biol; 2008; 437():1-50. PubMed ID: 18369961 [TBL] [Abstract][Full Text] [Related]
33. [A new approach to pharmacogenomics]. Fujita Y Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):149-57. PubMed ID: 11031744 [TBL] [Abstract][Full Text] [Related]
34. Progress in pharmacogenomics and its promise for medicine. Blake CA; Sobel BE Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537 [TBL] [Abstract][Full Text] [Related]
35. Cytochrome p450 part 3: drug interactions: essential concepts and considerations. Krau SD Nurs Clin North Am; 2013 Dec; 48(4):697-706. PubMed ID: 24295196 [TBL] [Abstract][Full Text] [Related]
36. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Lynch T; Price A Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140 [TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics, pharmacogenomics, and individualized medicine. Ma Q; Lu AY Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344 [TBL] [Abstract][Full Text] [Related]
38. Dosing recommendations for pharmacogenetic interactions related to drug metabolism. Filipski KK; Pacanowski MA; Ramamoorthy A; Feero WG; Freedman AN Pharmacogenet Genomics; 2016 Jul; 26(7):334-9. PubMed ID: 27058883 [TBL] [Abstract][Full Text] [Related]
39. Cytochromes P450: decision-making tools for personalized therapeutics. Murray M; Petrovic N Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482 [TBL] [Abstract][Full Text] [Related]